Carotid Body Tumor
Carotid Body Tumor
Carotid Body Tumor
Carotid Body Tumor
Carotid Body Tumor
Carotid Body Tumor
Carotid body tumors are the most common head-and-neck paragangliomas (65% of cases) and account for 30-40% hereditary rates with SDHx mutations; SDHD/SDHAF2 carry highest risk for multifocal disease while SDHB carries highest metastatic risk.
All patients should undergo germline SDHx mutation testing and genetic counseling given hereditary syndromic associations and cascade testing implications for family members.
The Shamblin classification predicts surgical ease, vascular reconstruction need, and intraoperative blood loss; degree of carotid encasement is the primary determinant and influences management strategy.
Preoperative embolization may reduce intraoperative blood loss in larger tumors but is not universally performed, with practice variation between centers.
Biochemical screening for catecholamine excess (plasma free metanephrines or 24-hour urine metanephrines) is recommended before surgery to prevent intraoperative hypertensive crisis, despite rare occurrence.
Gross total resection achieves cure in >90% of non-metastatic cases; observation is reasonable in elderly patients with small asymptomatic tumors, while radiotherapy is reserved for high-operative-risk patients.
Clearly describe the degree of carotid artery encasement using the Shamblin classification (state percentage of circumferential involvement and whether transmural infiltration is present), note the presence/absence of flow-limiting features, identify involvement of adjacent cranial nerves (glossopharyngeal, vagus, accessory, hypoglossal), and specify the main arterial supply (ascending pharyngeal artery); this information directly guides surgical planning and predicts operative complexity.